about
Pharmacokinetics of tenofovir following intravaginal and intrarectal administration of tenofovir gel to rhesus macaques.The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicidesPreclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicidePharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 PreventionConcentrations of dapivirine in the rhesus macaque and rabbit following once daily intravaginal administration of a gel formulation of [14C]dapivirine for 7 days.Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal TissuesInhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitorPharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial.The future of HIV microbicides: challenges and opportunities.Preclinical safety evaluation.Development of dapivirine vaginal ring for HIV prevention.The future of HIV prevention: prospects for an effective anti-HIV microbicide.Maraviroc and reverse transcriptase inhibitors combinations as potential preexposure prophylaxis candidates.Characterization of vaginal transmission of a simian human immunodeficiency virus (SHIV) encoding the reverse transcriptase gene from HIV-1 in Chinese rhesus macaques.A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women
P50
Q35666402-E222AD2C-B20B-42DA-AF1D-1546F7E41B2CQ35746066-DDD41CC5-FD57-4D83-AB1B-464B8B1CE489Q35941336-1264E350-68AB-4153-811B-175AFEA6B9DDQ36143276-546C07D8-67E6-4BE7-92C7-406AB74A1851Q36482710-047A2C03-8640-44CE-8468-162CDF01F844Q36756170-5E94541C-71C3-4E4A-B560-487ADD77C6B3Q37072072-A8BCED71-F63F-47E8-AF49-7E1EABC2C1DCQ37116845-46597DAD-2E92-4AD7-A2F0-A777A3785230Q37448790-54770D74-D4B5-4AAC-857D-131D3ED8663FQ38101264-D465D541-FBE5-400E-A1D1-33A36FAEE08FQ38159810-624610F5-6F70-4F20-8EBF-4A68ADF6F6EFQ40213117-08E7662D-5D54-4ECF-9E89-404AAF6EE0F3Q40800869-1214C746-9A97-4942-BCDD-55CD39B5EE22Q45386789-CE10EFB2-9109-4082-BE1D-71066F5FC6CDQ88024327-78117215-7B70-4D22-9B70-DB723F01C30E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jeremy Nuttall
@ast
Jeremy Nuttall
@en
Jeremy Nuttall
@es
Jeremy Nuttall
@nl
type
label
Jeremy Nuttall
@ast
Jeremy Nuttall
@en
Jeremy Nuttall
@es
Jeremy Nuttall
@nl
prefLabel
Jeremy Nuttall
@ast
Jeremy Nuttall
@en
Jeremy Nuttall
@es
Jeremy Nuttall
@nl
P106
P31
P496
0000-0003-1346-3357